×
UNH shares are surging approximately +6.70% in Tuesday premarket trading, pushing the stock toward the $300 level after closing at $281.36 on April 6, 2026. The primary catalyst is the Trump administration's finalization of a 2.48% increase in Medicare Advantage payment rates for 2027, announced by the Centers for Medicare & Medicaid Services (CMS) Monday evening — far above the near-flat 0.09% rate initially proposed in January.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
An AI-driven comparison of UnitedHealth Group (UNH) and CVS Health (CVS) points to UnitedHealth as the stronger investment heading into 2026. The analysis emphasizes UNH’s deeply integrated healthcare model, combining insurance, data analytics, pharmacy services, and care delivery into a single ecosystem. This structure provides resilience and earnings stability in an increasingly complex healthcare environment.
ExxonMobil (XOM) emerges as the AI-preferred energy stock in 2025, posting a 10% year-to-date gain compared with Chevron’s (CVX) 2% increase. Stronger upstream production, exposure to high-growth assets, and expanding low-carbon initiatives support XOM’s momentum. Tickeron’s AI models signal continued upside for XOM, while CVX shows signs of overbought conditions and elevated downside risk.
In the ever-shifting healthcare sector, CVS Health (CVS) and UnitedHealth Group (UNH) represent two powerhouse approaches: CVS as a retail pharmacy giant with integrated insurance and services, and UNH as a leading health insurer with diversified operations.
The medical companies segment has experienced a notable increase in performance, recording a weekly gain of +3.53%. This sector encompasses companies involved in the production and supply of pharmaceuticals and essential medical products, catering to a broad spectrum of healthcare needs. Their product offerings include surgical apparel, gloves, hospital furniture, fluid management solutions, and specialized equipment for cosmetic and surgical procedures.
Dive into the Managed Health Care sector's recent 5.23% growth with leading tickers $CI, $HUM, $MOH, $ELV, and $OSCR. Uncover the market dynamics steering this positive shift!
Explore the latest surge in Managed Healthcare! Dive into the performances of $HUM, $UNH, $ELV, $CI, and $CNC as the sector posts a promising +2.29% weekly gain.
CI (Cigna Corporation) is set to report its earnings on May 05, and the financial world is anticipating a 6.45% increase in earnings to $5.28 per share. This news has generated a lot of buzz among investors and analysts, who are closely monitoring the company's financial performance.
Managed Health Care Industry is on the rise, and one stock that stands out is Alignment Healthcare (ALHC) with an impressive 18.23% weekly gain. But what's driving this growth? A closer look at ALHC's technical indicators and recent earnings report reveals a compelling story for traders and investors. Read on to find out more
On Tuesday, February 21, Walmart will be announcing its earnings forecast for the upcoming year. This is a highly anticipated event, as Walmart is one of the largest retailers in the world, and its performance often reflects broader trends in the global economy. Walmart's most recent earnings report, released in November 2022, showed strong growth in e-commerce sales, which increased by 43%...
UnitedHealth Group posted fourth quarter earnings that exceeded analysts’ expectations. UnitedHealth’s adjusted profits for the three months ended in September came in at $5.34 a share, 17 cents ahead of the Wall Street consensus forecast. Revenues climbed +12.3% to $82.8 billion, vs. analysts’ estimates of $82.6 billion. Optum revenue climbed +16.5% to $47.9 billion. UnitedHealth's medical...
Cigna Corp. Q2 adjusted earnings came in at $6.22 a share, surpassing analysts’ expectations of $5.49 a share ( based on FactSet poll). The healthcare company's revenue climbed +5.45% year-over-year to $45.48 billion vs. analysts’ estimates of $44.49 billion, (according to FactSet). Evernorth segment, which covers pharmacy services, benefits management, care solutions and data and analytics,...
UnitedHealth Group Inc. reported its second-quarter adjusted earnings that exceeded analysts’ expectations. The company also boosted its earnings guidance for the full year. UnitedHealth’s adjusted earnings came in at $5.57 a share, exceeding the $5.21 a share expected by analysts surveyed by FactSet. Revenue of $80.3 billion also beat analysts’ forecasts for $79.7 billion (according to...
Now MIT researchers have developed a machine-learning algorithm that registers 3D images (like brain scans) 1000-plus times more quickly than traditional methods. Traditionally, 3D images are created via a technique called medical image registration.This process overlays two images, like MRIs, to compare and contrast anatomical information in great detail – an especially useful tool for doctors to gauge progress with a patient or treatment. MRI (magnetic resonance imaging) scans consist of hundreds of 2D images, all stacked on top of each other to form 3D images.
CVS Health Corp. reported fourth quarter earnings that exceeded analysts’ expectations. The healthcare company said it will resume offering insurance plans that offer 'Obamacare' subsidies. The company’s adjusted earnings for the three months ending in December fell -25% rom the year-ago quarter to $1.30 per share, 6 cents ahead of the Street consensus forecast. Revenues increased +4%...
The deal is expected to close in the second half of 2021.

The acquisition will see Change Healthcare combining with UnitedHealth’s OptumInsight unit to offer data analytics, software and other services to the health-care industry.

According to the two companies, the deal will help simplify services around medical care and lower costs.

Private-equity funds affiliated with Blackstone Group that own about 20% of Change Healthcare’s common stock have agreed to vote in favor of the deal.The deal is expected to increase UnitedHealth’s adjusted per-share earnings by 50 cents in 2022, the companies said.

The healthcare company also boosted its full-year profit guidance. The company’s  adjusted earnings for the three months ending in September came in at $1.84 per share, higher than analyst’ estimate of $1.77 per share.The figure reflects growth of +6.35% from the same period last year.  CVS total revenues surged +36.5% year-over-year to $64.8 billion in the quarter, again exceeding analysts' expectation of $63 billion. On a segment level, Pharmacy Services revenues rose +6.5%, on brand name drug price inflation as well as increased total pharmacy claims volume, partially offset by continued price compression and an increased generic dispensing rate – as indicated by the company.
  Healthcare provider Centene (NYSE: CNC) provides programs and services to under-insured and uninsured individuals in the United States.The company is set to release third quarter earnings results on October 22, but the stock ran in to some resistance ahead of the report. The daily chart shows that the stock has been trending lower over the last five months with a trend channel forming that defines the various cycles within the trend.
UnitedHealth  shares was downgraded by Jefferies, on concerns related to political risks and competition. Jefferies analyst David Windley lowered his rating on the healthcare company to hold from buy citing "the primary poison in the punch bowl, political risk, won't likely abate for at least another nine months." Windley also indicated that UnitedHealth  faces tough competition from Anthem, especially since the latter's market share is expanding while the two companies' geographies overlap. The analyst also cut his price target on UnitedHealth shares to $235 a share from $300.